eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2019
vol. 44
 
Share:
Share:
abstract:
Review paper

Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor  on cancer cells

Konrad Kwaśniak
1
,
Justyna Czarnik-Kwaśniak
1, 2, 3
,
Aleksandra Maziarz
1, 2
,
David Aebisher
1, 2
,
Kinga Zielińska
4
,
Bożenna Karczmarek-Borowska
4, 5
,
Jacek Tabarkiewicz
1, 2

  1. Centre for Innovative Research in Medical and Natural Sciences, Faculty of Medicine, University of Rzeszow, Poland
  2. Department of Immunology, Faculty of Medicine, University of Rzeszow, Poland
  3. Postgraduate School of Molecular Medicine, Medical University of Warsaw, Poland
  4. Department of Clinical Oncology, Clinical Provincial Hospital No. 1 in Rzeszow, Poland
  5. Department of Clinical Fundations of Physiotherapy, Medical Faculty, University of Rzeszow, Poland
(Centr Eur J Immunol 2019; 44 (2): 190-200)
Online publish date: 2019/07/30
View full text Get citation
 
PlumX metrics:
Cytokines are signalling proteins generated in most part by immune cells that have critical functions in cellular lifespan. Here we present recent data on three selected anti-inflammatory cytokines: interleukin (IL)-10, IL-4 and transforming growth factor  (TGF-). IL-10 inhibits the synthesis of major pro-inflammatory cytokines, chemokines, and mediates anti-inflammatory reactions. IL-4 is a multifunctional cytokine which plays a crucial role in the regulation of immune responses and is involved in processes associated with development and differentiation of lymphocytes and regulation of T cell survival. Transforming TGF-, which in normal cells or pre-cancerous cells, promotes proliferation arrest which represses tumour growth. In this review, we focus on the influence of IL-10, IL-4 and TGF- on various types of cancer as well as potential of these selected cytokines to serve as new biomarkers which can support effective therapies for cancer patients. This article is presented based on a review of the newest research results.
keywords:

cancer, anti-inflammatory cytokines, IL-10, IL-4, TGF-

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.